Bristol Myers Squibb Expands AI Research with NVIDIA Vera Rubin SuperPOD
Bristol Myers Squibb will deploy NVIDIA's DGX Vera Rubin NVL72 systems to enhance its AI capabilities across drug discovery and development, expanding its existing collaboration with the chipmaker to create the most powerful AI infrastructure in life sciences.